Level of Serum Lactate Dehydrogenase in Immune Thrombocytopenia
NCT07046013 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2025-07-01
Summary
Assessment of relation between serum lactate dehydrogenase and immune thrombocytopenia
Conditions
- Immune Thrombocytopenia (ITP)
Interventions
- DIAGNOSTIC_TEST
-
Lactate dehydrogenase
It's elevation at the time of diagnosis
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-08-31
- Primary Completion
- 2027-06-30
- Completion
- 2027-07-31
More Related Trials
-
Immune Thrombocytopenia Management in Adults
NCT05861297 ·Status: UNKNOWN ·Phase: PHASE4
-
Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura
NCT04056507 ·Status: COMPLETED
-
Longitudinal Cohort Study on Immune Thrombocytopenia Complicated With Acute Ischemic Stroke
NCT07070193 ·Status: NOT_YET_RECRUITING
-
The Expression of Immune Checkpoint CD28 rs1980422-related Single-nucleotide Polymorphisms in the Primary Immune Thrombocytopenia
NCT05468866 ·Status: UNKNOWN ·Phase: NA
-
Bleeding Prediction in Thrombocytopenia
NCT02306044 ·Status: COMPLETED
-
A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP)
NCT05566990 ·Status: COMPLETED ·Phase: PHASE3
-
"Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Thrombocytopenic Purpura in Children"
NCT07014904 ·Status: NOT_YET_RECRUITING
-
A Multicentre Investigation of 2 Cycles Rituximab Compared With Standard Regimen in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）
NCT02137681 ·Status: WITHDRAWN ·Phase: PHASE3
-
Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura
NCT07093606 ·Status: RECRUITING ·Phase: NA
-
An Investigation of rhTPO With Different Frequencies in the Management of ITP
NCT02139501 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
NCT06544499 ·Status: RECRUITING ·Phase: PHASE3
-
Diagnostic of Chronic Thrombocytopenia
NCT04071496 ·Status: COMPLETED
-
The Study of Different Dose Rituximab in the Treatment of ITP
NCT03258866 ·Status: COMPLETED ·Phase: PHASE4
-
Immune Thrombocytopenia (ITP) Immune-Genetic Assessment
NCT01196884 ·Status: UNKNOWN
-
Role of Acute Phase Proteins In Diagnosis of Immune Thrombocytopenia
NCT06715215 ·Status: RECRUITING ·Phase: NA
-
Immune Markers in Pediatric ITP on Second Line Therapy
NCT06093529 ·Status: NOT_YET_RECRUITING
-
Longitudinal Observational Study on Immune Thrombocytopenia
NCT07068425 ·Status: NOT_YET_RECRUITING
-
A Clinical Trial of Chidamide in the Management of Refractory ITP
NCT03838354 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT
NCT05944445 ·Status: UNKNOWN
-
A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)
NCT03164915 ·Status: COMPLETED ·Phase: PHASE3
-
Ultrasound to Detect Splenomegally in Patients With Isolated Thrombocytopenia
NCT07182760 ·Status: NOT_YET_RECRUITING
-
rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP
NCT01525836 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of FOXP3 Gene Polymorphisms and Serum Interleukin 10 in Patients With ITP
NCT05410249 ·Status: UNKNOWN
-
Risk Factors for Thrombosis in Immune Thrombocytopenia
NCT03820960 ·Status: COMPLETED
-
Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010
NCT06466824 ·Status: NOT_YET_RECRUITING